Drugs / BILR 355 BS
Trials 10
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 19 trials | ||||||
| Phase 1 | NCT02259868 | Jun → Sep 2005 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02256826 | Apr → Jun 2005 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02253901 | Mar → May 2005 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02257021 | Feb → May 2005 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02256774 | Oct 2004 → May 2005 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02253914 | Feb → Dec 2004 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02257008 | Mar → Dec 2003 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02253953 | Nov 2002 → Dec 2003 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02254538 | May 2002 → Feb 2003 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00294372 | Feb 2006 → Sep 2007 | HIV infectious disease | Boehringer Ingelheim | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BILR 355 BS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02253901 ↗ |
| Route | Oral | “oral administered” NCT00294372 ↗ |